Urology · Thousand Oaks, CA
NPI
1336205731
Since 2006
Specialty
Urology
Code 208800000X
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
415 Rolling Oaks Dr, Suite 260
Thousand Oaks, CA, 91361
Phone (805) 371-4707
Medicare paid, 2024
$692K
80,943 services
Medicare patients, 2024
1,929
Average age 77
Drug cost, 2024
$733K
3,296 prescriptions
Company payments, 2025
$589
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kyle K Himsl was code J3145 (injection, testosterone undecanoate, 1 mg), 63,000 times for 21 patients. In total Kyle K Himsl billed 80,943 services in 89 codes, and Medicare paid $692K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3145 Injection, testosterone undecanoate, 1 mg | Office | 63,000 | 21 | $1.49 | $94K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,500 | 24 | $4.99 | $27K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 3,506 | 12 | $2.18 | $7,656 |
| 99213 Office E&M - Established | Office | 1,619 | 1,131 | $69.72 | $113K |
| 81002 Clinical Chemistry | Office | 1,119 | 1,042 | $3.41 | $3,813 |
| 99214 Office E&M - Established | Office | 828 | 683 | $101.59 | $84K |
| 51798 Ultrasound - Nonspecific | Office | 535 | 365 | $9.87 | $5,281 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 461 | 418 | $13.56 | $6,252 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 351 | 46 | $136.12 | $48K |
| 52000 Cystourethroscopy | Office | 289 | 218 | $198.59 | $57K |
| 96372 Injection Administration | Office | 204 | 40 | $11.33 | $2,311 |
| 99212 Office E&M - Established | Office | 185 | 160 | $47.13 | $8,719 |
| 99204 Office E&M - New | Office | 159 | 159 | $132.08 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 129 | 62 | $64.43 | $8,311 |
| 51720 Chemotherapy Administration | Office | 122 | 17 | $70.95 | $8,656 |
By year: 2022 $601K for 75,170 services; 2023 $676K for 80,624 services; 2024 $692K for 80,943 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,119 | 1,042 | $3.41 | $3,813 |
Medicare prescription drug claims, 2024
In 2024, the drug Kyle K Himsl prescribed most often to Medicare patients was Tamsulosin Hcl, with 958 prescriptions and refills. In total Kyle K Himsl wrote 3,296 Medicare prescriptions that cost $733K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 958 | 2,618 | 305 | $18K |
| Finasteride Generic | 456 | 1,292 | 139 | $6,547 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 208 | 578 | 59 | $4,997 |
| Dutasteride Generic | 143 | 395 | 43 | $4,415 |
| Gemtesa Vibegron | 138 | 218 | 26 | $103K |
| Testosterone Generic | 127 | 241 | 41 | $33K |
| Testosterone Cypionate Generic | 79 | 164 | 24 | $2,871 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 78 | 78 | 64 | $226 |
| Methenamine Hippurate Generic | 67 | 150 | 19 | $3,940 |
| Myrbetriq Mirabegron | 62 | 146 | 20 | $68K |
| Bicalutamide Generic | 60 | 162 | 21 | $2,239 |
| Tadalafil Generic | 60 | 146 | 15 | $8,235 |
| Cefdinir Generic | 59 | 59 | 52 | $850 |
| Potassium Citrate Er Potassium Citrate | 55 | 145 | 15 | $6,035 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 54 | 54 | 40 | $460 |
Brand drugs: - claims; generic drugs: 3,010 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kyle K Himsl $589 ($589 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $179.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $179 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $64.65 |
| Procept Biorobotics Corporation PRCT | 1 | $53.97 |
| Mayne Pharma Commercial LLC | 2 | $40.8 |
| Ferring Pharmaceuticals Inc. | 2 | $38.36 |
| Verity Pharmaceuticals Inc. | 1 | $34.1 |
| Coloplast Corp | 2 | $31.15 |
| Immunitybio, Inc. IBRX | 1 | $29.26 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $28.54 |
| Endo USA, Inc. | 1 | $27.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.